Chemotherapy for squamous cell carcinoma of the head and neck: a progress report

American Journal of Otolaryngology
J H GlickS G Taylor

Abstract

This review highlights the most important recent advances in the chemotherapeutic management of patients with squamous cell carcinoma of the head and neck. Previous chemotherapy trials must be interpreted with caution in the absence of information concerning important prognostic variables, such as prior treatment, nutritional and performance status, and the heterogeneity of primary sites. In patients who have recurrent or metastatic disease, methotrexate, platinum, and bleomycin are three active drugs when used as single agents. There is no evidence that high dose methotrexate therapy is superior to more conventional weekly intravenous administration of methotrexate in the treatment of recurrent disease. Platinum is a new agent that has demonstrated activity against hematogenous as well as regional disease. In the absence of evidence of a dose-response curve for platinum, the lower dosage schedules that can be used with acceptable toxicity on an outpatient basis should be selected. Combination chemotherapy has resulted in a high proportion of objective responders and approximately 20 per cent complete remissions with any of several platinum containing regimens. However, the median duration of response remains short, and none of...Continue Reading

References

Jul 1, 1977·Clinical Radiology·V Shanta, S Krishnamurthi
Dec 1, 1977·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y CachinP Gerard
Oct 1, 1978·Cancer·P Y HoloyeR H Jesse
Jul 1, 1978·International Journal of Radiation Oncology, Biology, Physics·R R WeichselbaumJ Kirkwood
May 1, 1978·American Journal of Surgery·J D Khandekar, W D DeWys
Oct 1, 1978·American Journal of Surgery·M S StrongG B Healy
Mar 1, 1978·International Journal of Radiation Oncology, Biology, Physics·M AuerspergB Jereb
Sep 1, 1978·The Annals of Otology, Rhinology, and Laryngology·J B SnowL D Lowry
Nov 1, 1978·Cancer·C JacobsR L Goode
Sep 1, 1975·Cancer Treatment Reviews·Y Cachin, F Eschwege
Oct 1, 1975·American Journal of Surgery·C J Daly, E W Strong
May 1, 1972·American Journal of Surgery·W L Donegan, H S Harris
Jan 1, 1974·Cancer·J C ProbertM A Bagshaw
Sep 1, 1969·The Keio Journal of Medicine·Y SuzukiJ Matsukawa

❮ Previous
Next ❯

Citations

Feb 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C M NuttingK J Harrington
Aug 18, 2010·Biologics : Targets & Therapy·Mohamedtaki A TejaniRanee Mehra
Oct 1, 1982·American Journal of Surgery·M B SpauldingJ M Loré
Sep 1, 1987·The Journal of Pediatrics·S J Phelps, R A Helms
May 17, 2015·Surgical Oncology Clinics of North America·Philip Pancari, Ranee Mehra
Dec 1, 1988·The Journal of Allergy and Clinical Immunology·I AnnesiJ Lellouch
Mar 1, 1987·The American Journal of the Medical Sciences·K B RamanathanD M Mirvis
Jun 19, 2017·Journal of Cancer Research and Clinical Oncology·Mukundan Baskar Mannargudi, Subrata Deb
Aug 28, 2009·Expert Opinion on Pharmacotherapy·Daris FerrariPaolo Foa
Jun 27, 2017·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Kashappa Goud H Desai
Mar 7, 2007·Expert Review of Anticancer Therapy·John G Devlin, Corey J Langer
Feb 15, 1984·International Journal of Cancer. Journal International Du Cancer·J WennerbergC Tropé

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.